-
liquid-liquid phase separation (LLPS) and the above processes [Estrogen Receptor and Breast Cancer – Celebrating the 60th Anniversary of the Discovery of ER (1st ed, 2019, Springer Nature), Cell Reports
-
renal cancer, clear cell renal cell carcinoma (ccRCC). Research integrates state-of-the-art molecular biology using cell-based and animal models as well as system biology bioinformatics multiomics
-
. The initial appointment is for one year, with possible annual renewals for another two years based on performance. The start date is immediately but is flexible between July 2024 and October 2024. Essential
-
blood flow is restored. Repair injured heart through developing new cell-based therapy approaches. Responsible for stem cell isolation, culture, expansion, and induction with various bioactive molecules
-
renal cancer, clear cell renal cell carcinoma (ccRCC). Research integrates state-of-the-art molecular biology using cell-based and animal models as well as system biology bioinformatics multiomics
-
including RT-PCR, Western Blot, and immunostaining for histological analyses for at least 1 year. Applicant should have experience in molecular biology, cell-based technologies including cell culture and
-
a strong background in cell biology, molecular biology, biomedical engineering, genome editing, recombinant vector construction, induced pluripotent stem cell (iPSC) culture and differentiation, and
-
field or discipline, or the recognized terminal degree, or the foreign equivalent. Required Experience At least two years of prior laboratory experience with cell culture, protein and DNA manipulation
-
recognized terminal degree, or the foreign equivalent. Required Experience At least two years of prior laboratory experience with cell culture, protein and DNA manipulation, animal experimentation required
-
projects, particularly focusing on lung mesenchymal cell biology and pulmonary diseases (such as interstitial lung diseases). This person will conduct research experiments and analyze research data, ensure